Characterization of Cathepsin B in Mediating Silica Nanoparticle-Induced Macrophage Pyroptosis via an NLRP3-Dependent Manner

References

• Pan J, Wan D, Gong J. PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging. Chem Commun. 2011;47(12):3442–3444. doi:10.1039/c0cc05520d
   PubMed Web of Science ®Google Scholar
• Yetisen AK, Qu H, Manbachi A, et al. Nanotechnology in textiles. ACS Nano. 2016;10(3):3042–3068. doi:10.1021/acsnano.5b08176
   PubMed Web of Science ®Google Scholar
• Frohlich E, Roblegg E. Oral uptake of nanoparticles: human relevance and the role of in vitro systems. Arch Toxicol. 2016;90(10):2297–2314. doi:10.1007/s00204-016-1765-0
   PubMed Web of Science ®Google Scholar
• Pietroiusti A, Bergamaschi E, Campagna M, et al. The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group. Part Fibre Toxicol. 2017;14(1):47. doi:10.1186/s12989-017-0226-0
   PubMed Web of Science ®Google Scholar
• Yin H, Fang L, Wang L, et al. Acute silica exposure triggers pulmonary inflammation through macrophage pyroptosis: an experimental simulation. Front Immunol. 2022;13:874459. doi:10.3389/fimmu.2022.87445
   PubMed Web of Science ®Google Scholar
• Su DL, Lu ZM, Shen MN, Li X, Sun LY. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol. 2012;2012:347141. doi:10.1155/2012/347141
   PubMed Web of Science ®Google Scholar
• Tan S, Chen S. The mechanism and effect of autophagy, apoptosis, and pyroptosis on the progression of silicosis. Int J Mol Sci. 2021;22(15):8110. doi:10.3390/ijms22158110
   PubMed Web of Science ®Google Scholar
• Ishaq F, Sereesongsaeng N, Johnston MC, Scott CJ, Burden RE. Lysosomal cysteine proteases are mediators of cell death in macrophages following exposure to amorphous silica nanoparticles. Chem Biol Interact. 2022;356:109882. doi:10.1016/j.cbi.2022.109882
   PubMed Web of Science ®Google Scholar
• Hou W, Wei X, Liang J, et al. HMGB1-induced hepatocyte pyroptosis expanding inflammatory responses contributes to the pathogenesis of Acute-on-Chronic Liver Failure (ACLF). J Inflamm Res. 2021;14:7295–7313. doi:10.2147/JIR.S336626
   PubMed Web of Science ®Google Scholar
• Hu Y, Shi Y, Chen H, et al. Blockade of autophagy prevents the progression of hyperuricemic nephropathy through inhibiting NLRP3 inflammasome-mediated pyroptosis. Front Immunol. 2022;13:858494. doi:10.3389/fimmu.2022.858494
   PubMed Web of Science ®Google Scholar
• Wu QQ, Xu M, Yuan Y, et al. Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-alpha/ASK1/JNK pathway. Am J Physiol Heart Circ Physiol. 2015;308(9):H1143–1154. doi:10.1152/ajpheart.00601.2014
   PubMed Web of Science ®Google Scholar
• Bao W, Fan Q, Luo X, et al. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer. Oncol Rep. 2013;30(2):723–730. doi:10.3892/or.2013.2496
   PubMed Web of Science ®Google Scholar
• Tong B, Wan B, Wei Z, et al. Role of cathepsin B in regulating migration and invasion of fibroblast-like synoviocytes into inflamed tissue from patients with rheumatoid arthritis. Clin Exp Immunol. 2014;177(3):586–597. doi:10.1111/cei.12357
   PubMed Web of Science ®Google Scholar
• Tang Y, Cao G, Min X, et al. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation. J Physiol Biochem. 2018;74(4):503–510. doi:10.1007/s13105-018-0644-y
   PubMed Web of Science ®Google Scholar
• Wang Y, Jia L, Shen J, et al. Cathepsin B aggravates coxsackievirus B3-induced myocarditis through activating the inflammasome and promoting pyroptosis. PLoS Pathog. 2018;14(1):e1006872. doi:10.1371/journal.ppat.1006872
   PubMed Web of Science ®Google Scholar
• Hari A, Zhang Y, Tu Z, et al. Activation of NLRP3 inflammasome by crystalline structures via cell surface contact. Sci Rep. 2014;4:7281. doi:10.1038/srep07281
   PubMed Web of Science ®Google Scholar
• Chen J, Ding J, Wu Y, et al. Chromium oxide nanoparticle impaired osteogenesis and cellular response to mechanical stimulus. Int J Nanomedicine. 2021;16:6157–6170. doi:10.2147/IJN.S317430
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128. doi:10.1038/s41392-021-00507-5
   PubMed Web of Science ®Google Scholar
• Lo Giudice C, Yang J, Poncin MA, et al. Nanophysical mapping of inflammasome activation by nanoparticles via specific cell surface recognition events. ACS Nano. 2021;16(1):306–316. doi:10.1021/acsnano.1c06301
   PubMed Web of Science ®Google Scholar
• Kamikubo Y, Yamana T, Hashimoto Y, Sakurai T. Induction of oxidative stress and cell death in neural cells by silica nanoparticles. ACS Chem Neurosci. 2019;10(1):304–312. doi:10.1021/acschemneuro.8b00248
   PubMed Web of Science ®Google Scholar
• Zhou F, Liao F, Chen L, Liu Y, Wang W, Feng S. The size-dependent genotoxicity and oxidative stress of silica nanoparticles on endothelial cells. Environ Sci Pollut Res Int. 2019;26(2):1911–1920. doi:10.1007/s11356-018-3695-2
   PubMed Web of Science ®Google Scholar
• Costantini LM, Gilberti RM, Knecht DA. The phagocytosis and toxicity of amorphous silica. PLoS One. 2011;6(2):e14647. doi:10.1371/journal.pone.0014647
   PubMed Web of Science ®Google Scholar
• Jia H, Liu Y, Guo D, He W, Zhao L, Xia S. PM2.5-induced pulmonary inflammation via activating of the NLRP3/caspase-1 signaling pathway. Environ Toxicol. 2021;36(3):298–307. doi:10.1002/tox.23035
   PubMed Web of Science ®Google Scholar
• Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015;8:15–27. doi:10.2147/JIR.S51250
   PubMed Web of Science ®Google Scholar
• Faria SS, Costantini S, De lima VCC, et al. NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer. J Biomed Sci. 2021;28(1):26. doi:10.1186/s12929-021-00724-8
   PubMed Web of Science ®Google Scholar
• Lu F, Lan Z, Xin Z, et al. Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases. J Cell Physiol. 2020;235(4):3207–3221. doi:10.1002/jcp.29268
   PubMed Web of Science ®Google Scholar
• Bai H, Yang B, Yu W, Xiao Y, Yu D, Zhang Q. Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome. Exp Cell Res. 2018;362(1):180–187. doi:10.1016/j.yexcr.2017.11.015
   PubMed Web of Science ®Google Scholar
• Wang J, Wang L, Zhang X, et al. Cathepsin B aggravates acute pancreatitis by activating the NLRP3 inflammasome and promoting the caspase-1-induced pyroptosis. Int Immunopharmacol. 2021;94:107496. doi:10.1016/j.intimp.2021.107496
   PubMed Web of Science ®Google Scholar
• Campden RI, Zhang Y. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation. Arch Biochem Biophys. 2019;670:32–42. doi:10.1016/j.abb.2019.02.015
   PubMed Web of Science ®Google Scholar
• Bauer C, Duewell P, Mayer C, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59(9):1192–1199. doi:10.1136/gut.2009.197822
   PubMed Web of Science ®Google Scholar
• Halle A, Hornung V, Petzold GC, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9(8):857–865. doi:10.1038/ni.1636
   PubMed Web of Science ®Google Scholar
• Montaser M, Lalmanach G, Mach L. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol Chem. 2002;383(7–8):1305–1308. doi:10.1515/BC.2002.147
   PubMed Web of Science ®Google Scholar